PROVENGE® (sipuleucel-T)

PROVENGE® (sipuleucel-T)
Proper Name: Autologous Cellular Immunotherapy
Tradename: PROVENGE®
Manufacturer: Dendreon Corporation

Indication:

For the treatment of asymptomatic or minimally symptomatic metastatic castrate resistant (hormone refractory) prostate cancer.

OPEN HERE to see the related documents from FDA:
PROVENGE® (sipuleucel-T)